Fournier gangrene: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{SI}}
{{SI}}
{{SCC}}; {{AE}} {{JH}}.
{{SCC}}; {{AE}} {{YK}}; {{JH}}


{{Search infobox}}
{{Search infobox}}

Revision as of 21:53, 8 September 2016

WikiDoc Resources for Fournier gangrene

Articles

Most recent articles on Fournier gangrene

Most cited articles on Fournier gangrene

Review articles on Fournier gangrene

Articles on Fournier gangrene in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Fournier gangrene

Images of Fournier gangrene

Photos of Fournier gangrene

Podcasts & MP3s on Fournier gangrene

Videos on Fournier gangrene

Evidence Based Medicine

Cochrane Collaboration on Fournier gangrene

Bandolier on Fournier gangrene

TRIP on Fournier gangrene

Clinical Trials

Ongoing Trials on Fournier gangrene at Clinical Trials.gov

Trial results on Fournier gangrene

Clinical Trials on Fournier gangrene at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Fournier gangrene

NICE Guidance on Fournier gangrene

NHS PRODIGY Guidance

FDA on Fournier gangrene

CDC on Fournier gangrene

Books

Books on Fournier gangrene

News

Fournier gangrene in the news

Be alerted to news on Fournier gangrene

News trends on Fournier gangrene

Commentary

Blogs on Fournier gangrene

Definitions

Definitions of Fournier gangrene

Patient Resources / Community

Patient resources on Fournier gangrene

Discussion groups on Fournier gangrene

Patient Handouts on Fournier gangrene

Directions to Hospitals Treating Fournier gangrene

Risk calculators and risk factors for Fournier gangrene

Healthcare Provider Resources

Symptoms of Fournier gangrene

Causes & Risk Factors for Fournier gangrene

Diagnostic studies for Fournier gangrene

Treatment of Fournier gangrene

Continuing Medical Education (CME)

CME Programs on Fournier gangrene

International

Fournier gangrene en Espanol

Fournier gangrene en Francais

Business

Fournier gangrene in the Marketplace

Patents on Fournier gangrene

Experimental / Informatics

List of terms related to Fournier gangrene

Steven C. Campbell, M.D., Ph.D.; Associate Editor(s)-in-Chief: Yamuna Kondapally, M.B.B.S[1]; Jesus Rosario Hernandez, M.D. [2]

Template:Search infobox

Fournier gangrene
ICD-10 N49.8 (ILDS N49.81), N76.8
ICD-9 608.83
DiseasesDB 31119
MeSH D018934

Overview

Fournier gangrene is a type of necrotizing infection (gangrene) usually affecting the male genitals. It is a type of necrotizing fasciitis. It was first described by Baurienne in 1764 and is named after a French venereologist, Jean-Alfred Fournier following five cases he presented in clinical lectures in 1883.

Historical Perspective

Classification

Pathophysiology

Causes

Aetiology

In the majority of cases Fournier gangrene is a mixed infection caused by both aerobic and anaerobic bacteria.[1]

Differentiating Fournier gangrene from Other Diseases

Epidemiology and Demographics

Incidence

Only 600 cases of Fournier gangrene were reported in the world literature in the ten years since 1996, with most patients in their 60s or 70s with other concurrent illnesses.[2] However, Fournier's gangrene is not a reportable illness, and the condition is not uncommon, especially among diabetic individuals. A similar infection in women has been occasionally described.[3]

In Turkey it was reported that 46% of patients had diabetes mellitus[4] whilst other studies have identified approximately a third of patients having either diabetes, alcoholism or malnutrition, and 10% having medical immunosuppression (chemotherapy, steroids, malignancy).[5]

Risk Factors

Screening

Natural History, Complications, and Prognosis

Diagnosis

Diagnostic Criteria

History and Symptoms

Physical examination

Gallery

Genitourinary system

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Fournier gangrene is a urological emergency requiring intravenous antibiotics and debridement (surgical removal) of necrotic (dead) tissue. Despite such measures, the mortality rate overall is 40%, but 78% if sepsis is already present at the time of initial hospital admission.[4]

Antimicrobial Therapy

  • Fournier gangrene[6]
  • If caused by streptococcus species or clostridia
  • Polymicrobial
  • MRSA (methicillin resistant staphylococcus aureus) suspected

Surgery

Prevention

External links

References

  1. Thwaini A, Khan A, Malik A, Cherian J, Barua J, Shergill I, Mammen K (2006). "Fournier's gangrene and its emergency management". Postgrad Med J. 82 (970): 516–9. PMID 16891442.
  2. Vaz I (2006). "Fournier gangrene". Trop Doct. 36 (4): 203–4. PMID 17034687.
  3. Herzog W (1987). "[Fournier gangrene--also in females?]". Zentralbl Chir. 112 (9): 564–76. PMID 2956804.
  4. 4.0 4.1 Yanar H, Taviloglu K, Ertekin C, Guloglu R, Zorba U, Cabioglu N, Baspinar I (2006). "Fournier's gangrene: risk factors and strategies for management". World J Surg. 30 (9): 1750–4. PMID 16927060.
  5. Tahmaz L, Erdemir F, Kibar Y, Cosar A, Yalcýn O (2006). "Fournier's gangrene: report of thirty-three cases and a review of the literature". Int J Urol. 13 (7): 960–7. PMID 16882063.
  6. Gilbert, David (2015). The Sanford guide to antimicrobial therapy. Sperryville, Va: Antimicrobial Therapy. ISBN 978-1930808843.

Template:WH Template:WS